Share
1,983 Posts.
lightbulb Created with Sketch. 258
clock Created with Sketch. 09/09/24
22:44
Share
Originally posted by longreach:
↑
I believe i learn something new every day Stezza. I honestly thought that once the Company had submitted the final module to the FDA there would be an immediate jump in the share price and it would stay at a higher plateau - after all, the testing which the WISE device had been through over the past 6 months thereabouts was a period of uncertainty:
Expand
I can certainly see the CR argument. With $40+ million of debt, a fda no could see the end of this company. You have to balance that with probability which i would suggest is very low in my superficial and amateur opinion, but consequences are super high. I would think a cr would give necessary risk protection. But a pump will also go with this outcome.
(20min delay)